van Herpen, Carla M L <br/><br/>
Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Mar 2005 
 - 1899-909 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-04-1524  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adult<br/>Aged<br/>CD4-Positive T-Lymphocytes--immunology<br/>CD56 Antigen--analysis<br/>CD8-Positive T-Lymphocytes--immunology<br/>Carcinoma, Squamous Cell--drug therapy<br/>Female<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Interferon-gamma--biosynthesis<br/>Interleukin-12--administration & dosage<br/>Killer Cells, Natural--immunology<br/>Lymph Nodes--anatomy & histology<br/>Male<br/>Middle Aged<br/>RNA, Messenger--biosynthesis